ArticleMediterranean journal of hematology and infectious diseases2026
Sustained Response After a Six-Week Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia.
Tuba Güllü Koca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.